|

Trimethoprim Sulfamethoxazole Clinical Trials

4 actively recruiting trials across 1 location

Also known as: Co-Trimoxazole, co-trimoxazole

Pipeline

Phase 4: 1Phase 2/3: 3

Top Sponsors

  • Monash University3
  • Indiana University1

Indications

  • Myeloma3
  • Leukemia3
  • Cancer3
  • Non Hodgkin's Lymphoma2
  • Peritonsillar Abscess1

Other3 trials

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)
Phase 2/3
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Phase 2/3
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
Phase 2/3

Indianapolis, Indiana1 trial

Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections

Riley Hospital for Children

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.